Home
Chulabhorn Royal Pharmaceutical Manufacturing Facility, Chulabhorn Royal Academy, Honored with the "Value of the Land" Award 2024 for Public Health Promotion and Development
Bangkok, February 12, 2026 – The Chulabhorn Royal Pharmaceutical Manufacturing Facility of Chulabhorn Royal Academy has been honored with the "Value of the Land" (Ka Khong Phaen Din) Award for the Year 2024 in the category of Outstanding Organization in Public Health Promotion and Development, recognizing its significant and visible contributions to the nation.
The award ceremony was held at the Santi Maitri Building, Government House. Mr. Anutin Charnvirakul, Prime Minister, presided over the ceremony. Dr. Watchara Kanjanakawinkul , Director of The Chulabhorn Royal Pharmaceutical Manufacturing Facility, represented Chulabhorn Royal Academy in receiving the prestigious plaque.
The "Value of the Land" award is organized by the National Identity Committee, under the Office of the Permanent Secretary, Prime Minister's Office. It aims to honor individuals, organizations, or projects that have made extraordinary contributions to the country in various fields, including society, science, health, and education. Recipients are selected for their dedication, sacrifice, and for serving as exemplary role models in creating goodness for Thai society.
During the event, the Chulabhorn Royal Pharmaceutical Manufacturing Facility hosted an exhibition showcasing its medical innovations. Highlights included: IMCRANIB 100: The facility’s first line of Targeted Therapy (Tyrosine Kinase Inhibitor) tablets. This medication, which has undergone rigorous testing for quality, efficacy, and safety, officially received registration from the Food and Drug Administration (FDA), Ministry of Public Health on May 20, 2025.
This achievement marks a significant leap in Thailand’s pharmaceutical industry and medical personnel capabilities. It prepares the nation for the future production and research of various anti-cancer treatments, ensuring long-term drug security and sustainably improving the quality of life for Thai citizens.
Chulabhorn Royal Pharmaceutical Manufacturing Facility was established through the profound vision and Royal Aspiration of Professor Dr. Her Royal Highness Princess Chulabhorn Krom Phra Srisavangavadhana President of Chulabhorn Royal Academy and Chancellor of Chulabhorn Royal Academy Council, Deeply concerned by the difficulties Thai citizens face in accessing high-efficiency cancer medications, Her Royal Highness directed Chulabhorn Royal Academy to establish this facility in 2020. Located at Sattahip District, Chonburi Province, the plant’s mission is to produce high-potency pharmaceuticals, ensuring that cancer patients have equitable and thorough access to advanced treatments.
.jpg)
